Cargando…
ODP570 Immunotherapy and its Implications for the Future of Endocrinology: A Case Discussion of Pembrolizumab Induced Myxedema Coma
INTRODUCTION: Immunotherapy is a relatively new type of cancer treatment that has been successful in prolonging survival time and improving quality of life for patients with a wide variety of cancers.1 While these therapies do not usually have the same systemic toxicities seen in traditional chemoth...
Autores principales: | Coppinger, Anna, Meek, Jessica A, Demoranville, Beatriz, Al Dulaimi, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627527/ http://dx.doi.org/10.1210/jendso/bvac150.1636 |
Ejemplares similares
-
ODP499 Myxedema Coma: A Challenging Presentation of an Uncommon Disease
por: Figueroa, Alegyari, et al.
Publicado: (2022) -
Myxedema Coma Disguised as Alcohol Withdrawal
por: Pahwa, Dhivya, et al.
Publicado: (2021) -
SUN-584 Unusual Presentation Of Myxedema Coma
por: Murati, Jonila, et al.
Publicado: (2019) -
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019) -
ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022)